SLC16A1 and Alzheimer disease: Their results showed that myelin levels and expression of OL monocarboxylate transporter 1 (MCT1) decreased in APP/PS1 mice at 6 months, indicating that OL maturation was impaired and that OL dysfunction and early demyelination may lead to the progression of AD.